BenevolentAI
Biotechnology ResearchView the employees at
BenevolentAI-
Romain Studer Lead Bioinformatics Data Scientist
-
United Kingdom
-
Rising Star
Millie (Wenmin) Zhao AI Scientist at BenevolentAI-
London, England, United Kingdom
-
Rising Star
-
Rising Star
Mike Rawling Senior Principal Scientist, Medicinal Chemistry at BenevolentAI-
Greater Cambridge Area
-
Rising Star
Overview
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of this AI platform, its scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers the Company’s in-house drug pipeline and supports successful collaborations with AstraZeneca, as well as leading research and charitable institutions.
-